Related Experiment Videos
Cardiovascular drugs in pregnancy
J Widerhorn1, J N Rubin, W H Frishman
1University of Southern California School of Medicine, Los Angeles.
Cardiology Clinics
|November 1, 1987
Summary
Pregnancy alters how cardiovascular drugs work, affecting treatment safety and effectiveness for both mother and baby. This review summarizes current knowledge on managing heart conditions during pregnancy.
Area of Science:
- Cardiology
- Pharmacology
- Maternal-Fetal Medicine
Background:
- Cardiovascular drugs are frequently prescribed during pregnancy.
- Physiological changes in pregnancy impact drug pharmacokinetics.
- Maternal drug use poses risks to fetal development and newborns via lactation.
Purpose of the Study:
- To review the current understanding of cardiovascular drug use in pregnancy.
- To highlight the pharmacokinetic alterations during pregnancy.
- To discuss the implications for maternal and fetal health.
Main Methods:
- Literature review of existing studies on cardiovascular drug therapy in pregnancy.
- Analysis of pharmacokinetic changes during gestation.
- Evaluation of maternal, fetal, and neonatal outcomes.
Main Results:
- Pregnancy-induced physiological changes significantly alter drug absorption, distribution, metabolism, and excretion.
- Cardiovascular drug efficacy and toxicity profiles are modified.
- Data on specific drug effects and safety in pregnancy remain limited.
Conclusions:
- Careful consideration of pharmacokinetic changes is essential for safe and effective cardiovascular drug use in pregnancy.
- Further research is needed to fully elucidate the effects of cardiovascular drugs on maternal-fetal health.
- Individualized treatment strategies are crucial for pregnant patients requiring cardiovascular medications.